| Pharmaceutical active ingredients: |
| Budesonide |
| Available forms, composition and doses of Pulmicort HFA: |
| Powder, Metered; Inhalation; Budesonide 0.16 mg / dosePowder, Metered; Inhalation; Budesonide 0.32 mg / doseSuspension; Inhalation; Budesonide 0.1 mg / doseSuspension; Inhalation; Budesonide 0.2 mg / doseSuspension; Inhalation; Budesonide 0.5 mg / doseSuspension; Inhalation; Budesonide 1 mg / dose |
| Pulmicort HFA medical category: |
| Human:AdrenalsAntiasthmatic and COPD preparationsAnti-inflammatory agentsCorticosteroidsNasal decongestants and other nasal preparationsTopical corticosteroids used as nasal decongestants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07EA06 - BudesonideR01AD05 - Budesonide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AstraZeneca |
| Related documents and information about Pulmicort HFA: |
| Pulmicort prescribing information (PDF)Pulmicort Flexhaler prescribing information (PDF)Pulmicort Respules prescribing information (PDF)Pulmicort Turbohaler prescribing information (PDF) |